Lesley Ann Calhoun - 10 Aug 2021 Form 3 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role
Director
Signature
/s/ Daniella Beckman, as attorney-in-fact
Issuer symbol
TNGX
Transactions as of
10 Aug 2021
Net transactions value
$0
Form type
3
Filing time
12 Aug 2021, 20:36:49 UTC
Next filing
08 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNGX Stock Option (Right to Buy) 10 Aug 2021 Common Stock 84,929 $7.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in equally monthly installments over a period of 48 months from March 15, 2021.

Remarks:

Exhibit 24: Power of Attorney